查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1650991

全球生物处理容器市场

Bioprocess Containers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 271 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生物处理容器市场规模将达到 343 亿美元

2024 年全球生物处理容器市场规模估计为 95 亿美元，预计到 2030 年将达到 343 亿美元，2024 年至 2030 年的复合年增长率为 23.7%。报告中分析的细分市场之一，2D 生物处理容器，预计到分析期结束时复合年增长率为 27.1%，达到 223 亿美元。在分析期内，3D 生物处理容器部分预计将以 19.0% 的复合年增长率成长。

美国市场预计将达到 28 亿美元，中国市场复合年增长率将达到 22.6%

预计 2024 年美国生物加工容器市场价值将达到 28 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 51 亿美元，2024-2030 年分析期间的复合年增长率为 22.6%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 21.5% 和 19.4%。在欧洲，预计德国的复合年增长率约为 15.6%。

全球生物加工容器市场-主要趋势与驱动因素摘要

生物加工容器如何形塑生物製造格局？

生物处理容器已成为生物製造领域的关键组成部分，彻底改变了生物材料的处理、储存和加工方式。这些容器通常由先进的聚合物製成，专门设计用于安全有效地管理药品、疫苗和生技药品生产过程中生物加工的复杂需求。与传统的不銹钢系统不同，生物工艺容器提供了灵活的一次性替代方案，大大降低了交叉污染的风险并简化了您的製造作业。这在敏感生物製药的製造中尤其重要，因为保持无菌和确保产品完整性至关重要。生物处理容器的采用也支持了模组化、可扩展的生物製造设施日益增长的趋势，从而提高了製造过程的灵活性和效率。随着对生技药品和个人化医疗的需求不断增长，生物处理容器对于满足现代生物製造需求变得越来越重要。

生物处理容器对您的产业影响最大的是什么？

生物处理容器对生物製造业的几个关键领域产生重大影响。在製药业，它们广泛用于生产单株抗体、疫苗和其他生技药品，并且由于是一次性使用，因此无需在批次之间进行清洗或灭菌，从而简化了製造过程。这不仅减少了停机时间，还提高了整体生产效率并降低了污染风险。生物技术产业还在细胞和基因疗法的开发和生产中使用生物工艺容器，其中保持生物材料的无菌性和品质至关重要。此外，生物处理容器可用于试验和商业规模的生物製药生产，提供可轻鬆适应各种生产量的可扩展解决方案。生物製程容器也被受託製造厂商(CMO) 使用，提供满足多个客户的不同生产需求所需的灵活性和成本效益。因此，生物处理容器在优化生物製造过程和支持高品质生物製药的生产方面发挥着至关重要的作用。

为什么生物处理容器在生物製造上越来越受欢迎？

生物製程容器在生物製造领域的日益普及与产业向更灵活、更有效率和可扩展的生产方法的转变相辅相成。使用生物处理容器的主要原因之一是降低污染风险，这是生物製药生产的关键因素。由于是一次性使用，因此无需清洗或消毒，从而节省了时间并降低了营运成本，同时也最大限度地降低了批次之间交叉污染的风险。这对于生产多种产品或处理高度敏感生物材料的设施尤其重要。此外，生物处理容器提高了生产的灵活性，使製造商能够快速回应需求和生产要求的变化，而无需对其基础设施进行重大更改。此外，生物处理容器的模组化支持了製造设施向更小、更灵活的方向发展的趋势，这些设施可以根据需要轻鬆扩大或缩小。此外，一次性系统更容易处理，对环境的影响更小，使得生物处理容器在日益增加的监管和永续性压力下成为一个有吸引力的选择。随着生物製造业的不断发展，生物处理容器在实现更有效率、更具适应性和永续的生产方法方面发挥关键作用。

哪些因素推动了生物处理容器市场的成长？

生物处理容器市场的成长受到几个关键因素的推动。主要驱动因素是对单株抗体、疫苗、细胞和基因疗法等生技药品的需求不断增长，这些产品需要高度控制和无菌的製造环境。生物处理容器提供灵活、经济高效的解决方案，可降低污染风险，同时满足生技药品製造的严格要求。生物製药製造中一次性技术的趋势也是关键因素。此外，受託製造厂商(CMO) 的扩张以及对适应性、扩充性製造解决方案的需求也促进了市场的成长。生物处理容器使 CMO 能够有效率地管理不同客户的多种产品的生产。此外，生物处理技术的进步，例如开发更耐用、更坚固的容器材料，正在提高生物处理容器的性能和可靠性，进一步促进其应用。生物製造领域对永续性的日益关注，尤其是减少水和能源消耗，也推动了生物处理容器市场的成长，因为生物处理容器符合产业的永续性目标。这些因素结合在一起，使得生物处理容器对于未来的生物製造至关重要。

部分

类型（2D 生物製程容器、3D 生物製程容器、其他类型）、应用（上游工程、下游、製程开发）、最终用途（製药和生物製药公司、CRO 和 CMO、学术和研究机构）

受访企业范例（共38家）

  • Danaher Corporation
  • Fenner PLC
  • Fluids Control
  • GE Healthcare
  • Lonza Group AG
  • Meissner Filtration Products
  • Merck KgaA
  • Rim Bio Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP10730

Global Bioprocess Containers Market to Reach US$34.3 Billion by 2030

The global market for Bioprocess Containers estimated at US$9.5 Billion in the year 2024, is expected to reach US$34.3 Billion by 2030, growing at a CAGR of 23.7% over the analysis period 2024-2030. 2D Bioprocess Containers, one of the segments analyzed in the report, is expected to record a 27.1% CAGR and reach US$22.3 Billion by the end of the analysis period. Growth in the 3D Bioprocess Containers segment is estimated at 19.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 22.6% CAGR

The Bioprocess Containers market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2030 trailing a CAGR of 22.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.6% CAGR.

Global Bioprocess Containers Market - Key Trends and Drivers Summarized

How Are Bioprocess Containers Shaping the Landscape of Biomanufacturing?

Bioprocess containers have emerged as a critical component in the field of biomanufacturing, revolutionizing how biological materials are handled, stored, and processed. These containers, typically made from advanced polymers, are designed to safely and efficiently manage the complex needs of bioprocessing, particularly in the production of pharmaceuticals, vaccines, and biologics. Unlike traditional stainless steel systems, bioprocess containers offer a flexible, single-use alternative that significantly reduces the risk of cross-contamination and streamlines the production process. This is especially important in the production of sensitive biological products, where maintaining sterility and ensuring product integrity are paramount. The adoption of bioprocess containers also supports the growing trend towards modular and scalable biomanufacturing facilities, allowing for greater flexibility and efficiency in the production process. As the demand for biologics and personalized medicine continues to rise, bioprocess containers are becoming increasingly essential in meeting the needs of modern biomanufacturing.

Where Are Bioprocess Containers Making the Most Impact in the Industry?

Bioprocess containers are making a substantial impact across several key areas within the biomanufacturing industry. In the pharmaceutical sector, they are used extensively for the production of monoclonal antibodies, vaccines, and other biologics, where their single-use nature simplifies the production process by eliminating the need for cleaning and sterilization between batches. This not only reduces downtime but also enhances overall production efficiency and reduces the risk of contamination. The biotechnology industry is also leveraging bioprocess containers in the development and production of cell and gene therapies, where maintaining the sterility and quality of biological materials is critical. Additionally, bioprocess containers are used in the production of biopharmaceuticals at both the pilot and commercial scales, providing a scalable solution that can easily be adapted to different production volumes. The use of bioprocess containers in contract manufacturing organizations (CMOs) is another area of impact, where they offer the flexibility and cost-effectiveness needed to meet the diverse production demands of multiple clients. Across these applications, bioprocess containers are proving to be invaluable in optimizing the biomanufacturing process and supporting the production of high-quality biological products.

Why Are Bioprocess Containers Gaining Popularity in Biomanufacturing?

The growing popularity of bioprocess containers in biomanufacturing is closely linked to the industry's shift towards more flexible, efficient, and scalable production methods. One of the primary reasons for their adoption is the ability of bioprocess containers to reduce the risk of contamination, a critical factor in the production of biological products. Their single-use nature eliminates the need for cleaning and sterilization, which not only saves time and reduces operational costs but also minimizes the risk of cross-contamination between batches. This is particularly important in facilities that produce multiple products or work with highly sensitive biological materials. Moreover, bioprocess containers offer greater flexibility in production, allowing manufacturers to quickly adapt to changes in demand or production requirements without the need for significant infrastructure changes. The modularity of bioprocess containers also supports the trend towards smaller, more agile manufacturing facilities that can be easily scaled up or down as needed. Additionally, the ease of disposal and reduced environmental impact associated with single-use systems make bioprocess containers an attractive option in the context of increasing regulatory and sustainability pressures. As the biomanufacturing industry continues to evolve, bioprocess containers are playing a key role in enabling more efficient, adaptable, and sustainable production practices.

What Factors Are Driving the Growth of the Bioprocess Containers Market?

The growth in the bioprocess containers market is driven by several key factors. A major driver is the rising demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies, which require highly controlled and sterile manufacturing environments. Bioprocess containers offer a flexible and cost-effective solution that meets the stringent requirements of biologic production while reducing the risk of contamination. The trend towards single-use technologies in biomanufacturing is another significant factor, as these systems provide greater flexibility, reduce capital expenditures, and simplify regulatory compliance. The expansion of contract manufacturing organizations (CMOs) and their need for adaptable and scalable production solutions is also contributing to the market growth, as bioprocess containers allow CMOs to efficiently manage the production of multiple products for different clients. Additionally, ongoing advancements in bioprocessing technology, including the development of more durable and robust container materials, are enhancing the performance and reliability of bioprocess containers, further driving their adoption. The increasing focus on sustainability in biomanufacturing, with an emphasis on reducing water and energy consumption, is also supporting the growth of the bioprocess containers market, as these systems align with the industry's sustainability goals. Together, these factors are propelling the market forward, making bioprocess containers an integral part of the future of biomanufacturing.

SCOPE OF STUDY:

The report analyzes the Bioprocess Containers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (2D Bioprocess Containers, 3D Bioprocess Containers, Other Types); Application (Upstream Processes, Downstream Processes, Process Development); End-Use (Pharma & Biopharma Companies, CROs & CMOs, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Danaher Corporation
  • Fenner PLC
  • Fluids Control
  • GE Healthcare
  • Lonza Group AG
  • Meissner Filtration Products
  • Merck KgaA
  • Rim Bio Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bioprocess Containers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Biopharmaceutical Production Propels Growth of Bioprocess Containers
    • Single-Use Technologies Spur Demand for Disposable Bioprocess Containers
    • Here's the Story: How Personalized Medicine Expands the Addressable Market for Bioprocess Containers
    • Rising Demand for Flexible Manufacturing Accelerates Adoption of Bioprocess Containers
    • Innovations in Sterility and Contamination Control Drive Growth in High-Performance Bioprocess Containers
    • Advances in Material Science Expand Opportunities in Durable and Resilient Bioprocess Containers
    • Pharmaceutical Cold Chain Logistics Throws the Spotlight on Temperature-Controlled Bioprocess Containers
    • Growing Focus on Sustainability Generates Demand for Eco-friendly Bioprocess Containers
    • Increased Outsourcing in Biomanufacturing Fuels Demand for Bioprocess Containers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Upstream Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Upstream Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Downstream Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Downstream Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Process Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Process Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for 2D Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for 2D Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for 3D Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for 3D Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for CROs & CMOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for CROs & CMOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Bioprocess Containers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • JAPAN
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CHINA
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • EUROPE
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • GERMANY
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • UNITED KINGDOM
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030

IV. COMPETITION